Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
4
×
life sciences
national blog main
clinical trials
biotech
boston
national top stories
aldehyde
aldeyra therapeutics
allergic conjunctivitis
alnylam pharmaceuticals
amgen
black diamond therapeutics
bladder cancer
blueprint medicines
brexanalone
cancer
cancer drugs
cholesterol
clinical data
deciphera pharmaceuticals
depression
drugs
dry eye disease
eli lilly
endometral cancer
europe blog main
european society for medical oncology
fda
glioblastoma
inclisiran
jeff jonas
loxo oncology
major depressive disorder
mental illness
mirati therapeutics
neuroscience
new enterprise associates
new york
What
drug
phase
4
×
fda
therapeutics
closer
filing
medicines
new
positive
aldeyra
approval
biotech
black
brexanalone
bringing
cancer
cholesterol
clears
clinic
companies
data
depression
diamond
disclosed
eluded
eye
fighting
hits
hopes
hour
inched
inflammation
infusion
ipo
lead
leading
lines
lowering
mark
market
Language
unset
Current search:
phase
×
" boston top stories "
×
" boston blog main "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges